Press release
Sorafenib Market Size Projected To Reach $1.52 Billion By 2034 With A Cagr Of 4.2%
Sorafenib
What Is the Projected Growth of the Sorafenib Market?
The sorafenib market size will grow from $1.24 billion in 2024 to $1.3 billion in 2025 at a compound annual growth rate (CAGR) of 4.4%. This market growth is attributed to favorable government policies, increased drug approvals, apoptosis promotion in cancer cells, rising cancer incidences, and research on sorafenib.
The sorafenib market is expected to grow to $1.53 billion by 2029, at a CAGR of 4.2%. Growth is driven by increasing cancer incidences, especially thyroid, liver, and renal cancers, the rise in chronic diseases, a focus on precision medicine, and advancements in early diagnosis and treatment. Major trends include innovations in alternative therapies, hepatocellular carcinoma (HCC) advancements, drug delivery technology improvements, and renal cell carcinoma developments.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19199
What Are the Different Sorafenib Market Segments?
The sorafenibmarket covered in this report is segmented -
1) By Product: Patented Drugs, Generic Drugs
2) By Distribution Channel: Hospital Pharmacies, Drug Store And Retail Pharmacies, Online Pharmacies
3) By Application: Kidney Cancer, Liver Cancer, Thyroid Cancer
Subsegments:
1) By Patented Drugs: Nexavar
2) By Generic Drugs: Generic Sorafenib Tosylate, Other Generic Variants
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19199&type=smp
What Are the Primary Drivers Shaping the Sorafenib Market?
The increasing prevalence of cancer is expected to drive the growth of the sorafenib market. Cancer refers to conditions where abnormal cells divide uncontrollably and may invade healthy tissue. This rise is attributed to aging populations, lifestyle factors, environmental exposures, and improved diagnostic technologies. Sorafenib, a multi-kinase inhibitor, is crucial in treating cancers like advanced renal cell carcinoma and hepatocellular carcinoma. For example, in January 2023, the National Center for Biotechnology Information reported approximately 1,958,310 new cancer cases and 609,820 cancer-related deaths in the U.S. in 2023. Thus, the growing cancer cases are contributing to the expansion of the sorafenib market.
Which Companies Are Leading in the Sorafenib Market?
Major companies operating in the sorafenib market are Pfizer Inc., Bayer AG, AstraZeneca PLC, Novartis AG, Bristol Myers Squibb , Mylan N.V., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Amgen Inc., Cipla Limited, Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd., Exelixis Inc., Natco Pharma, Beacon Pharmaceuticals Ltd., Hetero Healthcare Ltd., Aprazer Healthcare Private Limited, Wellona Pharma, Anant Pharmaceuticals Pvt. Ltd., Intelicure Lifescience
What Trends Are Driving Growth in The Sorafenib Market?
Major Companies in the sorafenib market are focusing on developing affordable generic medicines, such as sorafenib tablets, to improve efficacy and patient compliance in cancer treatment. Generic medicines offer the same therapeutic benefits as brand-name drugs at a lower cost. For example, in June 2022, Dr. Reddy's Laboratories, an India-based pharmaceutical company, launched Sorafenib tablets in the US, providing an affordable generic version of Bayer's Nexavar for treating cancers like liver, kidney, and thyroid.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/sorafenib-global-market-report
What Are the Top Revenue-Generating Geographies in the Sorafenib Market?
North America was the largest region in the sorafenib market in 2024. The regions covered in the sorafenib market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Sorafenib Market?
2. What is the CAGR expected in the Sorafenib Market?
3. What Are the Key Innovations Transforming the Sorafenib Industry?
4. Which Region Is Leading the Sorafenib Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sorafenib Market Size Projected To Reach $1.52 Billion By 2034 With A Cagr Of 4.2% here
News-ID: 4050634 • Views: …
More Releases from The Business Research Company
Global Acrylic Powder Market Worth $77.43 Billion by 2029, Growing at 7.5% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Acrylic Powder Market Outlook: What Size And CAGR Are Anticipated By 2025?
In recent years, the market size of acrylic powder has experienced significant growth. It is projected to expand from $54.48 billion in 2024 to $57.94 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. Factors…
Toluene Derivatives Industry to Achieve $8.45 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Toluene Derivatives Market Grow by 2025 in Terms of Size and Growth?
In recent times, the market size of toluene derivatives has considerably grown. The market is projected to rise from $5.98 billion in 2024 to $6.4 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%.…
Sulfur Dioxide Market on Path to Hit $7.07 Billion by 2029 at 3.9% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Sulfur Dioxide Market Outlook: What Size And CAGR Are Anticipated By 2025?
The sulfur dioxide market has seen a consistent growth in its size over the past few years. Projected to expand from $5.89 billion in 2024 to $6.08 billion in 2025, it is speculated to increase at a compound…
Release Agents Market to Surpass $1.35 Billion by 2029 | Key Trends & Insights
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Release Agents Market Grow by 2025 in Terms of Size and Growth?
The market size of release agents has seen significant growth in recent years. The market is projected to expand from a value of $1.06 billion in 2024 to $1.11 billion in 2025, with a compound annual growth…
More Releases for Sorafenib
Sorafenib Tosylate Tablets Market to Observe Strong Development by 2030
Global Sorafenib Tosylate Tablets Market 2022-2028 - Global Industry Size, Supply Analysis, Price Analysis, Consumption and Production, Supplier and Cost Structure Analysis
Sorafenib Tosylate Tablets Market Overview
The recent market intelligence study by the research analysts at Market Business Insights (MBI) takes a deep dive into inner operations of the global Sorafenib Tosylate Tablets Market. It thoroughly examines the market landscape to give the readers an accurate insight into the current, as…
Global Sorafenib Market Research Report
This report studies the global Sorafenib market status and forecast, categorizes the global Sorafenib market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Pfizer Allergan Alnylam Pharmaceuticals Acceleron Pharma Biocon Bionomics CASI Pharmaceuticals Celgene Corporation Enzon Pharmaceuticals Five Prime Therapeutics Fujifilm Kyowa…
Sorafenib Global Industry Report - History, Present and Future 2018
GET SAMPLE REPORT @ https://www.research2reports.com/sample-report-pharmaceuticals/sorafenib-market/71807
The global market size of Sorafenib is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.
There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.
For geography segment, regional supply, application-wise and type-wise demand, major…
EMEA Sorafenib Market Research Report 2018- QY Research, Inc.
In this report, the EMEA Sorafenib market is valued at USD million in 2017 and is expected to reach USD million by the end of 2025, growing at a CAGR of % between 2017 and 2025.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Sorafenib for these regions, from 2013 to 2025 (forecast)
…
Global Sorafenib Sales Market Report 2017
Report Hive Market Research Released a New Research Report of 119 pages on Title " Global Sorafenib Sales Market Report 2017 "with detailed Analysis, Forecast and Strategies.
Sorafenib (co-created and co-advertised by Bayer and Onyx Pharmaceuticals as Nexavar),[1] is a kinase inhibitor tranquilize endorsed for the treatment of essential kidney tumor (progressed renal cell carcinoma), propelled essential liver growth (hepatocellular carcinoma), and radioactive iodine safe propelled thyroid carcinoma.
In this report, the…
Global Sorafenib Market Size, Share, Trends and Forecast 2017
Market Research Hub includes new market research report "Global Sorafenib Market Research Report 2017" to its huge collection of research reports. In this report, the global Sorafenib market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Request Free Sample Report - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1128597
Geographically, this report is segmented into several…
